Changsong Qi

11PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 23, 2026
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

|Mar 04, 2026
Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Chang Liu, Jiarui Li, Dan Liu

|Nov 29, 2025
Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer.

Jiarui Li, Lian Liu, Min Tao

|Oct 02, 2025
Optimizing CAR T cell therapy for solid tumours: a clinical perspective.

Jiarui Li, Chang Liu, Panpan Zhang

|Jul 10, 2025
A bispecific antibody-drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial.

Chang Liu, Dan Liu, Yinghua Ji

|Apr 17, 2025
Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer.

Jiarui Li, Min Tao, Lian Liu

Pageof 2

Frequent Collaborators

9 joint publications

Lin Shen

5 joint publications

Chang Liu

4 joint publications

Jian Li

4 joint publications

Jiarui Li